ETTX Entasis Therapeutics Holdings Inc

2,291

$2.19

$0.01

(0.46%)

Today

Market Cap	$104.8M
Volume (M)	68,834.00
52-Wk High	$3.88
52-Wk Low	$1.40

ST Data

Watchers

New Watcher Rank

Fundamentals

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022Globe Newswire • about 1 year ago

Six abstracts selected for presentation, including three oral presentationsWALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned ...

Share to Feed

Innoviva, Inc. Purchases 7,598,814 Shares of Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) StockTicker Report • over 1 year ago

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX Get Rating) major shareholder Innoviva, Inc. acquired 7,598,814 shares of Entasis Therapeutics stock in a transaction that occurred on Monday, July 11th. The stock was acquired at an average cost of $2.20 per share, with a total value of $16,...

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Major Shareholder Innoviva, Inc. Acquires 7,598,814 SharesZolmax • over 1 year ago

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX Get Rating) major shareholder Innoviva, Inc. bought 7,598,814 shares of the companys stock in a transaction on Monday, July 11th. The stock was purchased at an average cost of $2.20 per share, with a total value of $16,717,390.80. ...

Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.Business Wire • over 1 year ago

Innoviva, Inc. (Nasdaq: INVA) (Innoviva) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (Entasis) at a price of $2.20 per share, net to the seller in cash, without interest and less...

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, HR, MN, MICT, ETTXPR Newswire • over 1 year ago

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, HR, MN, MICT, ETTX SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, HR, MN, MICT, ETTX PR Newswire NEW YORK, June 22, 2022 NEW YORK, June 22, 2022 /PRNewswire/ --Halper Sadeh LLP, an investor rights law firm, is investigating the...

SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, ETTX, and TVTY Shareholders About Its Ongoing InvestigationsPR Newswire • over 1 year ago

SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, ETTX, and TVTY Shareholders About Its Ongoing Investigations SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, ETTX, and TVTY Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, June 21, 2022 NEW YORK, June 21, 2022 /PRNewswire/ -- If...

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTXPR Newswire • over 1 year ago

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTX INVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTX PR Newswire NEW YORK, June 15, 2022 NEW YORK, June 15, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following...

SHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLR Shareholders About Its Ongoing InvestigationsPR Newswire • over 1 year ago

SHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLR Shareholders About Its Ongoing Investigations SHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLR Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, June 14, 2022 NEW YORK, June 14, 2022 /PRNewswire/ -- If...

FY2023 Earnings Estimate for Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Issued By Cantor FitzgeraldTicker Report • over 1 year ago

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX Get Rating) Cantor Fitzgerald issued their FY2023 EPS estimates for shares of Entasis Therapeutics in a research note issued to investors on Monday, June 6th. Cantor Fitzgerald analyst L. Chen forecasts that the company will earn ($1.06...

Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual ConferenceGlobe Newswire • over 1 year ago

WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- EntasisTherapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations at the American Society for ...

Home
Symbol
ETTX
News

3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Latest ETTX News

View

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

Globe Newswire • about 1 year ago

Innoviva, Inc. Purchases 7,598,814 Shares of Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Stock

Ticker Report • over 1 year ago

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) Major Shareholder Innoviva, Inc. Acquires 7,598,814 Shares

Zolmax • over 1 year ago

Join the conversation.This is where all the magic happens.